BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roehrs T, Roth T. Drug-related Sleep Stage Changes: Functional Significance and Clinical Relevance. Sleep Med Clin 2010;5:559-70. [PMID: 21344068 DOI: 10.1016/j.jsmc.2010.08.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun H, Paixao L, Oliva JT, Goparaju B, Carvalho DZ, van Leeuwen KG, Akeju O, Thomas RJ, Cash SS, Bianchi MT, Westover MB. Brain age from the electroencephalogram of sleep. Neurobiol Aging 2019;74:112-20. [PMID: 30448611 DOI: 10.1016/j.neurobiolaging.2018.10.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
2 Dujardin S, Pijpers A, Pevernagie D. Prescription Drugs Used in Insomnia. Sleep Medicine Clinics 2018;13:169-82. [DOI: 10.1016/j.jsmc.2018.03.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
3 Roehrs T, Roth T. Insomnia as a path to alcoholism: tolerance development and dose escalation. Sleep 2018;41. [PMID: 29762764 DOI: 10.1093/sleep/zsy091] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
4 Singh LK, Nizamie SH, Tikka SK. Sleep architecture and EEG power spectra in recently detoxified alcohol dependent patients. Asian Journal of Psychiatry 2018;32:126-36. [DOI: 10.1016/j.ajp.2017.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Yeh WC, Lu SR, Wu MN, Lee KW, Chien CF, Fong YO, Li KY, Lai YL, Lin CJ, Li YS, Su CY, Wang YC, Lin YH, Chen TY, Tseng PT, Hsu CY. The impact of antiseizure medications on polysomnographic parameters: a systematic review and meta-analysis. Sleep Med 2021;81:319-26. [PMID: 33756282 DOI: 10.1016/j.sleep.2021.02.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Tan X, van Egmond L, Partinen M, Lange T, Benedict C. A narrative review of interventions for improving sleep and reducing circadian disruption in medical inpatients. Sleep Med 2019;59:42-50. [PMID: 30415906 DOI: 10.1016/j.sleep.2018.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hopkins SC, Dedic N, Koblan KS. Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans. Transl Psychiatry 2021;11:228. [PMID: 33879769 DOI: 10.1038/s41398-021-01331-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kwon Y, Gadi S, Shah NR, Stout C, Blackwell JN, Cho Y, Koene RJ, Mehta N, Mazimba S, Darby AE, Ferguson JD, Bilchick KC. Atrial Fibrillation and Objective Sleep Quality by Slow Wave Sleep. J Atr Fibrillation 2018;11:2031. [PMID: 30505377 DOI: 10.4022/jafib.2031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Hybschmann J, Topperzer MK, Gjærde LK, Born P, Mathiasen R, Sehested AM, Jennum PJ, Sørensen JL. Sleep in hospitalized children and adolescents: A scoping review. Sleep Med Rev 2021;59:101496. [PMID: 33984632 DOI: 10.1016/j.smrv.2021.101496] [Reference Citation Analysis]
10 Jobert M, Wilson FJ, Roth T, Ruigt GS, Anderer P, Drinkenburg WH, Bes FW, Brunovsky M, Danker-Hopfe H, Freeman J, van Gerven JM, Gruber G, Kemp B, Klösch G, Ma J, Penzel T, Peterson BT, Schulz H, Staner L, Saletu B, Svetnik V; IPEG Pharmaco-EEG Guidelines Committee. Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG). Neuropsychobiology 2013;67:127-67. [PMID: 23548759 DOI: 10.1159/000343449] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
11 Gigliotti F, Esposito D, Basile C, Cesario S, Bruni O. Sleep terrors-A parental nightmare. Pediatr Pulmonol 2021. [PMID: 33647192 DOI: 10.1002/ppul.25304] [Reference Citation Analysis]
12 Vallim JRDS, do Amaral FG, D'almeida V. Sleep parameters assessed by actigraphy in Fabry's disease patients: a proof-of-concept. Sleep Medicine 2020;69:213-6. [DOI: 10.1016/j.sleep.2020.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Reznik ME, Slooter AJC. Delirium Management in the ICU. Curr Treat Options Neurol 2019;21. [DOI: 10.1007/s11940-019-0599-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hermans LWA, van Gilst MM, Regis M, van den Heuvel LCE, Langen H, van Mierlo P, Krijn R, Hoondert B, Maass H, van Dijk JP, Leufkens TRM, Overeem S. Modeling sleep onset misperception in insomnia. Sleep 2020;43:zsaa014. [PMID: 32016410 DOI: 10.1093/sleep/zsaa014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
15 Ma J, Svetnik V, Snyder E, Lines C, Roth T, Herring WJ. Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects. Sleep 2014;37:1609-19. [PMID: 25197807 DOI: 10.5665/sleep.4068] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
16 Gibson RM, Ray LB, Laforge G, Owen AM, Fogel SM. 24-h polysomnographic recordings and electrophysiological spectral analyses from a cohort of patients with chronic disorders of consciousness. J Neurol 2020;267:3650-63. [DOI: 10.1007/s00415-020-10076-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Léger D, Debellemaniere E, Rabat A, Bayon V, Benchenane K, Chennaoui M. Slow-wave sleep: From the cell to the clinic. Sleep Medicine Reviews 2018;41:113-32. [DOI: 10.1016/j.smrv.2018.01.008] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 12.8] [Reference Citation Analysis]
18 Edinger JD, Buysse DJ, Deriy L, Germain A, Lewin DS, Ong JC, Morgenthaler TI. Quality measures for the care of patients with insomnia. J Clin Sleep Med 2015;11:311-34. [PMID: 25700881 DOI: 10.5664/jcsm.4552] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
19 Dudysová D, Janků K, Šmotek M, Saifutdinova E, Kopřivová J, Bušková J, Mander BA, Brunovský M, Zach P, Korčák J, Andrashko V, Viktorinová M, Tylš F, Bravermanová A, Froese T, Páleníček T, Horáček J. The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action. Front Pharmacol 2020;11:602590. [PMID: 33343372 DOI: 10.3389/fphar.2020.602590] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Batlle E, Lizano E, Viñas M, Dolors Pujol M. 1,4-Benzodiazepines and New Derivatives: Description, Analysis, and Organic Synthesis. In: Vašková J, Vaško L, editors. Medicinal Chemistry. IntechOpen; 2019. [DOI: 10.5772/intechopen.79879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Palesh O, Scheiber C, Kesler S, Mustian K, Koopman C, Schapira L. Management of side effects during and post-treatment in breast cancer survivors. Breast J 2018;24:167-75. [DOI: 10.1111/tbj.12862] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
22 Garg H. Role of optimum diagnosis and treatment of insomnia in patients with hypertension and diabetes: A review. J Family Med Prim Care 2018;7:876-83. [PMID: 30598926 DOI: 10.4103/jfmpc.jfmpc_337_17] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Ellenbogen JM, Pace-Schott EF. Drug-induced sleep: theoretical and practical considerations. Pflugers Arch 2012;463:177-86. [PMID: 21953011 DOI: 10.1007/s00424-011-1033-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Rosenberg R, Citrome L, Drake CL. Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies. Neuropsychiatr Dis Treat 2021;17:2549-66. [PMID: 34393484 DOI: 10.2147/NDT.S297504] [Reference Citation Analysis]
25 Scalo J, Desai P, Rascati K. Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample. Qual Life Res 2015;24:1223-33. [PMID: 25432884 DOI: 10.1007/s11136-014-0842-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
26 Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgrad Med 2021;133:1-9. [PMID: 33423590 DOI: 10.1080/00325481.2020.1857992] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Simon SL, Byars KC. Behavioral Treatments for Non-Rapid Eye Movement Parasomnias in Children. Curr Sleep Medicine Rep 2016;2:152-7. [DOI: 10.1007/s40675-016-0049-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Dujardin S, Pijpers A, Pevernagie D. Prescription Drugs Used in Insomnia. Sleep Med Clin 2020;15:133-45. [PMID: 32386689 DOI: 10.1016/j.jsmc.2020.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]